Using advanced computer methods to predict how patients will respond to drugs
Novel computational approaches to predict drug response and combination effects
This study is looking at how your unique genes can help doctors predict which medications will work best for you, so you can get more personalized and effective treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10807111 on NIH RePORTER |
What this research studies
This research focuses on developing innovative computational techniques to enhance the accuracy of predicting how individual patients will respond to various medications based on their unique genetic makeup. By analyzing extensive genomic and pharmacogenomic data, the project aims to create reliable models that can tailor drug therapies to improve patient outcomes. Additionally, the research seeks to understand the mechanisms of action of drugs, which could lead to identifying new uses for existing medications. Patients may benefit from more effective and personalized treatment options as a result of these advancements.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with complex diseases who are seeking personalized medication strategies based on their genetic profiles.
Not a fit: Patients who do not have complex diseases or those who are not interested in personalized medicine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective drug therapies for patients, improving treatment outcomes.
How similar studies have performed: Other research has shown promising results using computational methods to predict drug responses, indicating that this approach has potential for success.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Xie, Yang — Ut Southwestern Medical Center
- Study coordinator: Xie, Yang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.